141 related articles for article (PubMed ID: 28414793)
1. Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.
Xu Z; Yan Y; Xiao L; Dai S; Zeng S; Qian L; Wang L; Yang X; Xiao Y; Gong Z
PLoS One; 2017; 12(4):e0175977. PubMed ID: 28414793
[TBL] [Abstract][Full Text] [Related]
2. Blockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-AKT signaling increases radiosensitivity of K-RAS mutated human tumor cells in vitro by affecting DNA repair.
Toulany M; Kasten-Pisula U; Brammer I; Wang S; Chen J; Dittmann K; Baumann M; Dikomey E; Rodemann HP
Clin Cancer Res; 2006 Jul; 12(13):4119-26. PubMed ID: 16818713
[TBL] [Abstract][Full Text] [Related]
3. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
[TBL] [Abstract][Full Text] [Related]
4. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells.
Xia S; Zhao Y; Yu S; Zhang M
Cancer Biother Radiopharm; 2010 Jun; 25(3):317-23. PubMed ID: 20578837
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous inhibition of EGFR and PI3K enhances radiosensitivity in human breast cancer.
Li P; Zhang Q; Torossian A; Li ZB; Xu WC; Lu B; Fu S
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e391-7. PubMed ID: 22414288
[TBL] [Abstract][Full Text] [Related]
6. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
7. Digoxin enhances radiation response in radioresistant A549 cells by reducing protein phosphatase 2A.
Lee JY; Kim MS; Lee MS; Ju JE; Chung N; Jeong YK
Biosci Rep; 2017 Nov; 37(6):. PubMed ID: 29070518
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitizing effects of Cyclocarya paliurus polysaccharide on hypoxic A549 and H520 human non-small cell lung carcinoma cells.
Zhang F; Fan B; Mao L
Int J Mol Med; 2019 Oct; 44(4):1233-1242. PubMed ID: 31364726
[TBL] [Abstract][Full Text] [Related]
9. Diosmetin enhances the sensitivity of radiotherapy by suppressing homologous recombination in endometrial cancer.
Hu Z; Cai B; Wang M; Wen X; Geng A; Hu X; Xue R; Mao Z; Jiang Y; Wan X
Cell Cycle; 2020 Nov; 19(22):3115-3126. PubMed ID: 33064975
[TBL] [Abstract][Full Text] [Related]
10. Targeting the AKT/cyclin D1 pathway to overcome intrinsic and acquired radioresistance of tumors for effective radiotherapy.
Shimura T
Int J Radiat Biol; 2017 Apr; 93(4):381-385. PubMed ID: 27910734
[TBL] [Abstract][Full Text] [Related]
11. Effect and Mechanism of Tanshinone I on the Radiosensitivity of Lung Cancer Cells.
Yan Y; Su W; Zeng S; Qian L; Chen X; Wei J; Chen N; Gong Z; Xu Z
Mol Pharm; 2018 Nov; 15(11):4843-4853. PubMed ID: 30216081
[TBL] [Abstract][Full Text] [Related]
12. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway.
Lei Y; Li HX; Jin WS; Peng WR; Zhang CJ; Bu LJ; Du YY; Ma T; Sun GP
Int J Radiat Biol; 2013 Dec; 89(12):1079-86. PubMed ID: 23875954
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine kinase AKT is frequently activated in human bile duct cancer and is associated with increased radioresistance.
Tanno S; Yanagawa N; Habiro A; Koizumi K; Nakano Y; Osanai M; Mizukami Y; Okumura T; Testa JR; Kohgo Y
Cancer Res; 2004 May; 64(10):3486-90. PubMed ID: 15150102
[TBL] [Abstract][Full Text] [Related]
14. Intracellular calcium promotes radioresistance of non-small cell lung cancer A549 cells through activating Akt signaling.
Wang Y; He J; Zhang S; Yang Q
Tumour Biol; 2017 Mar; 39(3):1010428317695970. PubMed ID: 28351325
[TBL] [Abstract][Full Text] [Related]
15.
Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
[No Abstract] [Full Text] [Related]
16. Radio-sensitization of human leukaemic MOLT-4 cells by DNA-dependent protein kinase inhibitor, NU7441.
Tichy A; Durisova K; Salovska B; Pejchal J; Zarybnicka L; Vavrova J; Dye NA; Sinkorova Z
Radiat Environ Biophys; 2014 Mar; 53(1):83-92. PubMed ID: 24100951
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis.
Che SM; Zhang XZ; Hou L; Song TB
Cancer Invest; 2010 Aug; 28(7):679-88. PubMed ID: 20486853
[TBL] [Abstract][Full Text] [Related]
18. A novel role for NFIA in restoring radiosensitivity in radioresistant NSCLC cells by downregulating the AKT and ERK pathways.
Sun C; Li Y; Tan Y; Zhang H; Liang Y; Zeng J; Yu J; Zou H
Biochem Biophys Res Commun; 2019 Aug; 515(4):558-564. PubMed ID: 31178144
[TBL] [Abstract][Full Text] [Related]
19. NSCLC cells demonstrate differential mode of cell death in response to the combined treatment of radiation and a DNA-PKcs inhibitor.
Yu L; Shang ZF; Hsu FM; Zhang Z; Tumati V; Lin YF; Chen BP; Saha D
Oncotarget; 2015 Feb; 6(6):3848-60. PubMed ID: 25714019
[TBL] [Abstract][Full Text] [Related]
20. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
